Page 4 - இருதய நிகழ்வுகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from இருதய நிகழ்வுகள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In இருதய நிகழ்வுகள் Today - Breaking & Trending Today

VASCEPA® (Icosapent Ethyl) Found in Prespecified and Post Hoc Analyses to Significantly Reduce ...


Press release content from Globe Newswire. The AP news staff was not involved in its creation.
VASCEPA® (Icosapent Ethyl) Found in Prespecified and Post Hoc Analyses to Significantly Reduce .
Amarin Corporation plcMarch 17, 2021 GMT
28% and 32% significant reductions in first and total strokes, respectively, demonstrated with VASCEPA compared to placebo, as well as reductions in first and total ischemic strokes each by 36%, without increasing hemorrhagic stroke, in statin-treated patients with elevated cardiovascular risk
Consistent reductions in overall stroke and in ischemic stroke observed across multiple subgroups
Administration of pure icosapent ethyl, VASCEPA, represents a novel clinical approach to stroke reduction
REDUCE-IT® STROKE abstract receives prestigious Paul Dudley White International Scholar Award to recognize the authors with the highest ranked abstract from the United States at the International Stroke Conference 2021 ....

United States , New Jersey , United Arab Emirates , Clin Cardiol , Coll Cardiol , Alina Kolomeyer , Steven Ketchum , Deepakl Bhatt , Paul Dudley White , American Heart Association , Harvard Medical School , Professor Of Medicine At Harvard Medical School , Exchange Commission , Paul Dudley White International Scholar Award , International Stroke Conference , Amarin Corporation , Journal Of The American College Cardiology , European Union , European Medicines Agency , Committee For Medicinal Products Human Use , A Report From The American Heart Association , Executive Director , Interventional Cardiovascular Programs , Paul Dudley White Award , New England Journal , American College ,

VASCEPA® (Icosapent Ethyl) Found in Prespecified and Post Hoc Analyses to Significantly Reduce Stroke in At-Risk Patients in Analyses of Landmark REDUCE-IT® Study Presented at International Stroke Conference 2021


Share:
28% and 32% significant reductions in first and total strokes, respectively, demonstrated with VASCEPA compared to placebo, as well as reductions in first and total ischemic strokes each by 36%, without increasing hemorrhagic stroke, in statin-treated patients with elevated cardiovascular risk
Consistent reductions in overall stroke and in ischemic stroke observed across multiple subgroups
Administration of pure icosapent ethyl, VASCEPA, represents a novel clinical approach to stroke reduction
REDUCE-IT® STROKE abstract receives prestigious Paul Dudley White International Scholar Award to recognize the authors with the highest ranked abstract from the United States at the International Stroke Conference 2021
DUBLIN, Ireland and BRIDGEWATER, N.J., March 17, 2021 (GLOBE NEWSWIRE) Amarin Corporation plc (NASDAQ:AMRN) today announced the presentation of REDUCE-IT® STROKE at the International Stroke Conference 2021, being held virtually from March 17 ....

United States , New Jersey , United Arab Emirates , Clin Cardiol , Coll Cardiol , Alina Kolomeyer , Steven Ketchum , Deepakl Bhatt , Paul Dudley White , American Heart Association , Harvard Medical School , Professor Of Medicine At Harvard Medical School , Exchange Commission , Paul Dudley White International Scholar Award , International Stroke Conference , Amarin Corporation , Journal Of The American College Cardiology , European Union , European Medicines Agency , Committee For Medicinal Products Human Use , A Report From The American Heart Association , Executive Director , Interventional Cardiovascular Programs , Paul Dudley White Award , New England Journal , American College ,

Amarin Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update


Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Amarin Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
Amarin Corporation plcFebruary 25, 2021 GMT
Record Revenue of $614.1 Million and $167.3 Million for Full Year and Fourth Quarter 2020 Despite COVID-19 Impact
Received Positive CHMP Opinion for VAZKEPA ®
in Europe and Continue to Advance Commercial Launch Plans for Europe
Management to Host Conference Call Today at 7:30 a.m. ET
DUBLIN, Ireland and BRIDGEWATER, N.J., Feb. 25, 2021 (GLOBE NEWSWIRE) Amarin Corporation plc (NASDAQ:AMRN), today announced financial results for the quarter and year ended December 31, 2020 and provided an update on company operations. ....

United States , Hong Kong , New Jersey , United Arab Emirates , Coll Cardiol , Clin Cardiol , Johnf Thero , European Commission , Exchange Commission , Exchange Commission Regulation , Hong Kong Department Of Health , Amarin Corporation , Chinese Society Of Cardiology , European Union , Chinese National Medical Products Administration , Journal Of The American College Cardiology , European Medicines Agency , Hikma Pharmaceuticals , Committee For Medicinal Products Human Use , Symphony Health , Record Revenue , Full Year , Fourth Quarter , Advance Commercial Launch Plans , Host Conference Call Today , Key Amarin Achievements ,